Selank
Also known as Selanc, TP-7
A synthetic peptide derived from tuftsin, an immunomodulatory peptide. Approved in Russia for anxiety and nootropic effects.
Regulatory Pathway
Dosing Protocol
Typical Dose
250-500 mcg intranasal 2-3x daily
Frequency
2-3x daily
Duration
14-21 days typical
Timing & Administration
Administer via Intranasal spray (most common) or subcutaneous injection. Frequency: 2-3x daily.
Popular Uses
Mechanism of Action
Modulates BDNF expression, influences serotonin and dopamine metabolism, affects GABAergic system, possesses immunomodulatory properties from tuftsin backbone.
Research Summary
Evidence level: clinical trials. Clinical status: Approved in Russia - Not FDA approved (Removed from Category 2 Sept 2024).
Side Effects & Safety
Important Warnings
- Non-sedative and non-addictive
- May potentiate benzodiazepine effects.
References
No references available.
Related Peptides
Browse all →Synthetic peptide derived from ACTH (4-10) fragment with added Pro-Gly-Pro sequence. Used clinically in Russia for stroke, traumatic brain injury, and cognitive disorders.
View profileA neuropeptide mixture derived from porcine brain tissue, indicated for neurological conditions including stroke recovery, cognitive decline, and traumatic brain injury.
View profileA potent cognitive-enhancing peptide derived from angiotensin IV. Reported to be 10 million times more potent than BDNF at promoting synaptogenesis.
View profile